A dose-dependent response is seen with an increasing number of cardiometabolic diseases and cognitive decline.
Post-COVID conditions are common among adult survivors
May 25, 2022
There was a more than twofold risk of acute pulmonary embolism and respiratory signs and symptoms among survivors aged 18 to 64 and ≥65 years.
Prevalence of risk factors for Alzheimer’s, related dementias identified
May 20, 2022
The highest prevalence seen for high blood pressure and not meeting aerobic physical activity guidelines, followed by obesity.
‘Tragic milestone’: One million American lives lost to COVID-19
May 12, 2022
President Biden has ordered U.S. flags to be flown at half-staff in honor of those lost.
COVID-19 drug Paxlovid might also fight long COVID
May 06, 2022
A series of case reports shows some success with Paxlovid in treating patients with long COVID.
FDA OKs marketing of new test to help diagnose Alzheimer disease
May 06, 2022
The test is indicated for patients 55 years and older who present with cognitive impairment and are being evaluated for Alzheimer’s disease and cognitive decline.